![William Burns](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
William Burns
Président chez
MOLECULAR PARTNERS AG
Fortune : 494 837 $ au 30/09/2026
Profil
Mr. William M.
Burns is an Advisor at Healthcare Royalty Management LLC, a Chairman at Molecular Partners, Inc., a Chairman at Molecular Partners AG, an Independent Non-Executive Vice Chairman at Mesoblast Ltd., a Chairman at Vestergaard Frandsen SA, a Chairman at Health Innovation Challenge Fund, a Chairman at Okairos SRL and a Chairman at Vestergaard SARL. He is on the Board of Directors at Mesoblast Ltd. and The Institute of Cancer Research: Royal Cancer Hospital.
Mr. Burns was previously employed as a Member-Governors Board by The Wellcome Trust Ltd., a Chairman by Okairos AG, a Chairman by Biotie Therapies Oy, a Member-Supervisory Board by Crucell NV, a Senior Independent Non-Executive Director by Shire Plc, a Non-Executive Director by Roche Holding AG, a Non-Executive Director by Shire Group Plc, a Senior Independent Director by Shire Pharmaceuticals, Inc., a Non-Executive Director by Chugai Pharmaceutical Co., Ltd., a Chief Executive Officer-Pharmaceuticals Division by Roche Group, a Chief Executive Officer by Roche Pharmaceuticals, Inc., a Chairman by Interpharma, a Chairman by Masters Pharmaceuticals Ltd., and an Advisor by Novo Holdings A/S (Denmark).
He also served on the board at F.
Hoffmann-La Roche Ltd., Genentech, Inc., European Federation of Pharmaceutical Industries & Assns and International Federation of Pharmaceutical Manufacturers.
He received his undergraduate degree from the University of Strathclyde.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
MESOBLAST LIMITED 0,02% | 27/08/2026 | 226 250 ( 0,02% ) | 332 119 $ | 30/09/2026 |
| 31/12/2025 | 40 922 ( 0,1% ) | 162 718 $ | 30/09/2026 |
Postes actifs de William Burns
| Sociétés | Poste | Début |
|---|---|---|
| MESOBLAST LIMITED | Directeur/Membre du Conseil | 06/03/2014 |
| MOLECULAR PARTNERS AG | Président | 18/04/2018 |
Healthcare Royalty Management LLC
 Healthcare Royalty Management LLC Investment ManagersFinance Healthcare Royalty invests in companies located in the United States. The firm targets companies operating in the fields of biopharmaceutical, biotechnology and medical device sectors. It provides financing for buyout transactions in the form of royalty monetization, corporate financing and debt. | Consultant / Advisor | 01/01/2020 |
Molecular Partners, Inc.
 Molecular Partners, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company | Président | 01/01/2018 |
The Institute of Cancer Research: Royal Cancer Hospital
 The Institute of Cancer Research: Royal Cancer Hospital Miscellaneous Commercial ServicesCommercial Services Operates as a cancer research institution | Directeur/Membre du Conseil | 01/01/2014 |
Health Innovation Challenge Fund | Président | - |
Vestergaard Frandsen SA
 Vestergaard Frandsen SA Medical/Nursing ServicesHealth Services Manufactures insecticidal nets and water purification equipment | Président | 01/01/2017 |
Okairos SRL
 Okairos SRL Pharmaceuticals: MajorHealth Technology Manufactures drugs | Président | 07/09/2011 |
Vestergaard SARL
 Vestergaard SARL Apparel/FootwearConsumer Non-Durables Manufactures mosquito nets and storage bags | Président | - |
Anciens postes connus de William Burns
| Sociétés | Poste | Fin |
|---|---|---|
| ░░░ ░░░░░░░░ ░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░ ░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
Formation de William Burns
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
93
Relations au 1er degré
28
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 28 |
|---|---|
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
Roche Holding AG
 Roche Holding AG Pharmaceuticals: MajorHealth Technology Operates as a research-focused healthcare company with combined focus in pharmaceuticals and diagnostics | Health Technology |
The Wellcome Trust Ltd.
 The Wellcome Trust Ltd. Investment Trusts/Mutual FundsMiscellaneous Provides welfare and charitable services | Miscellaneous |
F. Hoffmann-La Roche Ltd.
 F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Crucell NV
 Crucell NV Pharmaceuticals: MajorHealth Technology Develops, produces and markets vaccines, proteins and antibodies | Health Technology |
Roche Pharmaceuticals, Inc.
 Roche Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Provides research and development services | Commercial Services |
International Federation of Pharmaceutical Manufacturers
 International Federation of Pharmaceutical Manufacturers BiotechnologyHealth Technology Provides biopharmaceutical research services | Health Technology |
Vestergaard Frandsen SA
Vestergaard Frandsen SA Medical/Nursing ServicesHealth Services Manufactures insecticidal nets and water purification equipment | Health Services |
Shire Plc
 Shire Plc Pharmaceuticals: MajorHealth Technology Develops and markets medicines for patients with rare diseases | Health Technology |
The Institute of Cancer Research: Royal Cancer Hospital
The Institute of Cancer Research: Royal Cancer Hospital Miscellaneous Commercial ServicesCommercial Services Operates as a cancer research institution | Commercial Services |
Chugai Pharmaceutical Co., Ltd.
 Chugai Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Operates as a holding company whose subsidiaries manufactures & sells pharmaceutical products | Health Technology |
Novo Holdings A/S (Denmark)
 Novo Holdings A/S (Denmark) Investment ManagersFinance Functions as an alternative investment manager | Finance |
Biotie Therapies Oy
 Biotie Therapies Oy Pharmaceuticals: MajorHealth Technology Engages in research, development and commercialization of pharmaceutical products | Health Technology |
Roche Group
 Roche Group Real Estate DevelopmentFinance Manages real estate properties | Finance |
University of Strathclyde
 University of Strathclyde Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Mesoblast Ltd.
 Mesoblast Ltd. BiotechnologyHealth Technology Engages in the development and commercialization of biological and adult stem cells products | Health Technology |
Healthcare Royalty Management LLC
Healthcare Royalty Management LLC Investment ManagersFinance Healthcare Royalty invests in companies located in the United States. The firm targets companies operating in the fields of biopharmaceutical, biotechnology and medical device sectors. It provides financing for buyout transactions in the form of royalty monetization, corporate financing and debt. | Finance |
European Federation of Pharmaceutical Industries & Assns
 European Federation of Pharmaceutical Industries & Assns Miscellaneous Commercial ServicesCommercial Services Operates as a trade association which promotes pharmaceutical discovery and development | Commercial Services |
Shire Pharmaceuticals, Inc.
 Shire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Molecular Partners AG
 Molecular Partners AG BiotechnologyHealth Technology Engages in discovery, development and commercialization of biopharmaceutical products | Health Technology |
Okairos AG
 Okairos AG Pharmaceuticals: MajorHealth Technology Discovers and develops preventive and therapeutic vaccines against human chronic infectious diseases | Health Technology |
Okairos SRL
Okairos SRL Pharmaceuticals: MajorHealth Technology Manufactures drugs | Health Technology |
Masters Pharmaceuticals Ltd.
 Masters Pharmaceuticals Ltd. Specialty StoresRetail Trade Provides global healthcare solutions | Retail Trade |
Interpharma
 Interpharma Miscellaneous Commercial ServicesCommercial Services Operates as an association of research-based pharmaceutical companies | Commercial Services |
Health Innovation Challenge Fund | |
Shire Group Plc
 Shire Group Plc RestaurantsConsumer Services Operates restaurants | Consumer Services |
Molecular Partners, Inc.
Molecular Partners, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company | Health Technology |
Vestergaard SARL
Vestergaard SARL Apparel/FootwearConsumer Non-Durables Manufactures mosquito nets and storage bags | Consumer Non-Durables |
